GLP-3

GLP-3 is Azyven Research's catalog name for a research peptide studied across three metabolic signaling systems. Researchers use this type of peptide to examine how signals involving appetite, glucose regulation, insulin activity, and energy use can interact within the same experimental model.

More specifically, GLP-3 research focuses on coordinated activity at the GLP-1, GIP, and glucagon receptors and its relationship with glucose biology, appetite signaling, energy expenditure, insulin sensitivity, and body-weight-related research.

Technical Identity: GLP-3 is commonly characterized in this research category as a synthetic peptide with triple receptor-agonist activity involving the GLP-1, GIP, and glucagon receptor systems. Product-specific identity should be confirmed from applicable supplier documentation.

Azyven Research GLP-3 is supplied exclusively for laboratory research and analytical use.

What is GLP-3?

GLP-3 is a triple-receptor agonist research peptide designed to engage GLP-1, GIP, and glucagon receptors. These three receptor systems participate in different but interconnected aspects of metabolic regulation.

Why is GLP-3 studied?

GLP-3 has attracted research interest because it extends the concept of single- and dual-receptor metabolic agonism to three coordinated signaling pathways.

Researchers study this approach to investigate whether combining GLP-1, GIP, and glucagon receptor activity produces metabolic responses that differ from engaging one or two of these pathways.

What research areas are associated with GLP-3?

GLP-1-Receptor Research
GLP-1 signaling is associated with glucose-dependent insulin signaling, appetite, satiety, and nutrient-related metabolic regulation.

GIP-Receptor Research
GIP is an incretin hormone involved in nutrient sensing, insulin signaling, and metabolic communication.

Glucagon-Receptor Research
Glucagon signaling participates in glucose and energy metabolism and adds a distinct component to the triple-receptor profile.

Body-Weight & Energy-Balance Research
Studies of triple agonism have examined appetite, body-weight biology, and energy expenditure.

Glucose & Insulin-Signaling Research
The three-receptor model is used to explore glucose handling, insulin sensitivity, and broader metabolic regulation.

What have studies found?

Published research on triple GLP-1/GIP/glucagon receptor agonism has explored multiple metabolic outcomes.

Multi-receptor activity
Studies demonstrate that the compound class can engage all three target receptor systems, creating a distinct signaling profile.

Body-weight-related research
Research has reported changes involving body weight and energy-balance measures.

Glucose regulation
Studies have examined glucose control, insulin sensitivity, and related metabolic outcomes.

Human clinical research
Triple-receptor agonism has progressed into human clinical investigation, expanding the evidence base beyond earlier mechanistic research.

Evidence context
The contribution of each receptor and the way the three signals interact remain important research questions; findings should be understood as effects of the combined receptor profile rather than attributed to one pathway alone.

How does GLP-3 relate to other Azyven products?

GLP-3 provides Azyven's triple-receptor metabolic research model.

Researchers may compare it with Semaglutide, which focuses on GLP-1 receptor signaling, and Tirzepatide, which combines GIP and GLP-1 receptor agonism. Cagrilintide + Semaglutide offers another multi-pathway approach through amylin and GLP-1 biology.

Researchers can ask Aria Jr. to compare these receptor profiles and associated research areas.

What am I purchasing?

Azyven Research GLP-3 is supplied as a lyophilized research material in the strength selected above.

Available Strengths: 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg
Form: Lyophilized powder
Product Type: Research Peptide
Intended Use: Laboratory research only

Research Use Only: Azyven Research products are intended for laboratory research purposes only. They are not intended for human or veterinary use, consumption, administration, or clinical application.